
Katherine Peebles
Examiner (ID: 5291, Phone: (571)272-6247 , Office: P/1617 )
| Most Active Art Unit | 1617 |
| Art Unit(s) | 1617 |
| Total Applications | 638 |
| Issued Applications | 202 |
| Pending Applications | 126 |
| Abandoned Applications | 331 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17440831
[patent_doc_number] => 20220061336
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => Natural Concentrated Composition for Killing and Repelling Pests
[patent_app_type] => utility
[patent_app_number] => 17/412189
[patent_app_country] => US
[patent_app_date] => 2021-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2277
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17412189
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/412189 | Natural Concentrated Composition for Killing and Repelling Pests | Aug 24, 2021 | Abandoned |
Array
(
[id] => 17290800
[patent_doc_number] => 20210386639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-16
[patent_title] => Foaming Topical Antimicrobial Cleaning Compositions
[patent_app_type] => utility
[patent_app_number] => 17/405462
[patent_app_country] => US
[patent_app_date] => 2021-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19451
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17405462
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/405462 | Foaming Topical Antimicrobial Cleaning Compositions | Aug 17, 2021 | Abandoned |
Array
(
[id] => 18550838
[patent_doc_number] => 20230248838
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => CENTRAL NERVOUS SYSTEM DELIVERY OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
[patent_app_type] => utility
[patent_app_number] => 18/004633
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19303
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -69
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18004633
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/004633 | CENTRAL NERVOUS SYSTEM DELIVERY OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS | Jul 29, 2021 | Pending |
Array
(
[id] => 17334555
[patent_doc_number] => 20220000886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => PHARMACEUTICAL CARRIERS CAPABLE OF pH DEPENDENT RECONSTITUTION AND METHODS FOR MAKING AND USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/378458
[patent_app_country] => US
[patent_app_date] => 2021-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48635
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -48
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17378458
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/378458 | Pharmaceutical carriers capable of pH dependent reconstitution and methods for making and using same | Jul 15, 2021 | Issued |
Array
(
[id] => 18724355
[patent_doc_number] => 20230338497
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => METHOD FOR PREPARING A VACCINE COMPOSITION FROM LYOPHILIZED ANTIGENS
[patent_app_type] => utility
[patent_app_number] => 18/004980
[patent_app_country] => US
[patent_app_date] => 2021-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5605
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18004980
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/004980 | METHOD FOR PREPARING A VACCINE COMPOSITION FROM LYOPHILIZED ANTIGENS | Jul 7, 2021 | Pending |
Array
(
[id] => 17342006
[patent_doc_number] => 20220008337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => PHARMACEUTICAL LIQUID COMPOSITIONS OF MELOXICAM
[patent_app_type] => utility
[patent_app_number] => 17/368367
[patent_app_country] => US
[patent_app_date] => 2021-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18956
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17368367
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/368367 | PHARMACEUTICAL LIQUID COMPOSITIONS OF MELOXICAM | Jul 5, 2021 | Abandoned |
Array
(
[id] => 18201150
[patent_doc_number] => 11583521
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-21
[patent_title] => Long-acting injection dosage form of beta 3 adrenoreceptor agonists
[patent_app_type] => utility
[patent_app_number] => 17/364469
[patent_app_country] => US
[patent_app_date] => 2021-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10577
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17364469
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/364469 | Long-acting injection dosage form of beta 3 adrenoreceptor agonists | Jun 29, 2021 | Issued |
Array
(
[id] => 17503405
[patent_doc_number] => 20220096507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => Parenteral Pharmaceutical Composition Comprising Azacitidine or Decitabine in DMSO
[patent_app_type] => utility
[patent_app_number] => 17/423210
[patent_app_country] => US
[patent_app_date] => 2021-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6260
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17423210
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/423210 | Parenteral Pharmaceutical Composition Comprising Azacitidine or Decitabine in DMSO | Jun 28, 2021 | Abandoned |
Array
(
[id] => 17168625
[patent_doc_number] => 20210322295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => Cleansing Compositions
[patent_app_type] => utility
[patent_app_number] => 17/304578
[patent_app_country] => US
[patent_app_date] => 2021-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6188
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17304578
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/304578 | Cleansing compositions | Jun 22, 2021 | Issued |
Array
(
[id] => 17124399
[patent_doc_number] => 20210299167
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => STABLE IODINE-CONTAINING ANTIMICROBIAL TEAT DIP COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/346615
[patent_app_country] => US
[patent_app_date] => 2021-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8705
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17346615
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/346615 | STABLE IODINE-CONTAINING ANTIMICROBIAL TEAT DIP COMPOSITIONS | Jun 13, 2021 | Pending |
Array
(
[id] => 19608070
[patent_doc_number] => 12156929
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-03
[patent_title] => Topical antimicrobial composition
[patent_app_type] => utility
[patent_app_number] => 17/926267
[patent_app_country] => US
[patent_app_date] => 2021-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6214
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17926267
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/926267 | Topical antimicrobial composition | Jun 7, 2021 | Issued |
Array
(
[id] => 17312661
[patent_doc_number] => 20210401709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => PROCESS FOR DEPIGMENTING KERATIN MATERIALS USING THIOPYRIDINONE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/340594
[patent_app_country] => US
[patent_app_date] => 2021-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4780
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 254
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17340594
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/340594 | PROCESS FOR DEPIGMENTING KERATIN MATERIALS USING THIOPYRIDINONE COMPOUNDS | Jun 6, 2021 | Abandoned |
Array
(
[id] => 17241944
[patent_doc_number] => 20210361687
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => COMBINATION PRODUCTS OF TOBRAMYCIN COMPOUNDS AND DEXAMETHASONE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/327703
[patent_app_country] => US
[patent_app_date] => 2021-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42556
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 280
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17327703
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/327703 | Combination products of tobramycin compounds and dexameihasone compounds | May 21, 2021 | Issued |
Array
(
[id] => 18434150
[patent_doc_number] => 20230181444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => COMPOSITIONS COMPRISING ORGANO-SILANOL COMPOUNDS, AND APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 17/999321
[patent_app_country] => US
[patent_app_date] => 2021-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8928
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999321
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/999321 | Compositions comprising organo-silanol compounds, and applications | May 19, 2021 | Issued |
Array
(
[id] => 19960263
[patent_doc_number] => 12329735
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-17
[patent_title] => Azelaic acid esters in the treatment of insulin resistance
[patent_app_type] => utility
[patent_app_number] => 17/318586
[patent_app_country] => US
[patent_app_date] => 2021-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 2439
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17318586
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/318586 | Azelaic acid esters in the treatment of insulin resistance | May 11, 2021 | Issued |
Array
(
[id] => 20341933
[patent_doc_number] => 12465649
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-11
[patent_title] => Paclitaxel-hyaluronic acid conjugate in the treatment of non-muscle invasive bladder cancer
[patent_app_type] => utility
[patent_app_number] => 17/315962
[patent_app_country] => US
[patent_app_date] => 2021-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 325
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17315962
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/315962 | Paclitaxel-hyaluronic acid conjugate in the treatment of non-muscle invasive bladder cancer | May 9, 2021 | Issued |
Array
(
[id] => 17539847
[patent_doc_number] => 11304951
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-04-19
[patent_title] => Dosing regimens associated with extended release paliperidone injectable formulations
[patent_app_type] => utility
[patent_app_number] => 17/314330
[patent_app_country] => US
[patent_app_date] => 2021-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 17063
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 203
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17314330
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/314330 | Dosing regimens associated with extended release paliperidone injectable formulations | May 6, 2021 | Issued |
Array
(
[id] => 18391746
[patent_doc_number] => 20230159964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => METHOD TO PRODUCE BIOCATALYTICAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/997724
[patent_app_country] => US
[patent_app_date] => 2021-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5689
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17997724
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/997724 | METHOD TO PRODUCE BIOCATALYTICAL COMPOSITIONS | May 5, 2021 | Pending |
Array
(
[id] => 16990121
[patent_doc_number] => 20210228541
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => FORMULATION BASED ON VITAMIN E OR AN ESTER THEREOF FOR TREATING BACTERIAL AND FUNGAL BIOFILMS
[patent_app_type] => utility
[patent_app_number] => 17/231761
[patent_app_country] => US
[patent_app_date] => 2021-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3164
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17231761
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/231761 | FORMULATION BASED ON VITAMIN E OR AN ESTER THEREOF FOR TREATING BACTERIAL AND FUNGAL BIOFILMS | Apr 14, 2021 | Abandoned |
Array
(
[id] => 18724159
[patent_doc_number] => 20230338279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => NASAL SPRAY FORMULATION WITH MOISTURIZING BENEFITS
[patent_app_type] => utility
[patent_app_number] => 17/918790
[patent_app_country] => US
[patent_app_date] => 2021-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8032
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17918790
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/918790 | NASAL SPRAY FORMULATION WITH MOISTURIZING BENEFITS | Apr 12, 2021 | Pending |